1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The December issue of the Schedule includes several new/revised listings of note:

• Belzutifan (Welireg) - new medicine
• Dienogest (Vizanne) - new medicine
• Vedolizumab (Entyvio) - new indication

Read Summary of PBS changes